-
2
-
-
20044366163
-
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
-
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-96.
-
(2005)
N Engl J Med
, vol.352
, pp. 987-996
-
-
Stupp, R.1
Mason, W.P.2
Van Den Bent, M.J.3
Weller, M.4
Fisher, B.5
Taphoorn, M.J.6
-
3
-
-
77951003656
-
Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States
-
Grossman SA, Ye X, Piantadosi S, Desideri S, Nabors LB, Rosenfeld M, et al. Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States. Clin Cancer Res 2010;16:2443-9.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 2443-2449
-
-
Grossman, S.A.1
Ye, X.2
Piantadosi, S.3
Desideri, S.4
Nabors, L.B.5
Rosenfeld, M.6
-
4
-
-
65349121788
-
Effects of radiotherapywith concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
-
Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al. Effects of radiotherapywith concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009;10:459-66.
-
(2009)
Lancet Oncol
, vol.10
, pp. 459-466
-
-
Stupp, R.1
Hegi, M.E.2
Mason, W.P.3
Van Den Bent, M.J.4
Taphoorn, M.J.5
Janzer, R.C.6
-
5
-
-
84961290723
-
Glioma cells escaped from cytotoxicity of temozolomide and vincristine by communicatingwith human astrocytes
-
Chen W, Wang D, Du X, He Y, Chen S, Shao Q, et al. Glioma cells escaped from cytotoxicity of temozolomide and vincristine by communicatingwith human astrocytes. Med Oncol 2015;32:43.
-
(2015)
Med Oncol
, vol.32
, pp. 43
-
-
Chen, W.1
Wang, D.2
Du, X.3
He, Y.4
Chen, S.5
Shao, Q.6
-
6
-
-
84927966760
-
Treatment of poorly differentiated glioma using a combination of monoclonal antibodies to extracellular connexin-43 fragment, temozolomide, and radiotherapy
-
Yusubalieva GM, Baklaushev VP, Gurina OI, Zorkina YA, Gubskii IL, Kobyakov GL, et al. Treatment of poorly differentiated glioma using a combination of monoclonal antibodies to extracellular connexin-43 fragment, temozolomide, and radiotherapy. Bull Exp Biol Med 2014;157: 510-5.
-
(2014)
Bull Exp Biol Med
, vol.157
, pp. 510-515
-
-
Yusubalieva, G.M.1
Baklaushev, V.P.2
Gurina, O.I.3
Zorkina, Y.A.4
Gubskii, I.L.5
Kobyakov, G.L.6
-
7
-
-
84897457122
-
Temozolomide resistance in glioblastoma cells occurs partly through epidermal growth factor receptor-mediated induction of connexin 43
-
Munoz JL, Rodriguez-Cruz V, Greco SJ, Ramkissoon SH, Ligon KL, Rameshwar P. Temozolomide resistance in glioblastoma cells occurs partly through epidermal growth factor receptor-mediated induction of connexin 43. Cell Death Dis 2014;5:e1145.
-
(2014)
Cell Death Dis
, vol.5
-
-
Munoz, J.L.1
Rodriguez-Cruz, V.2
Greco, S.J.3
Ramkissoon, S.H.4
Ligon, K.L.5
Rameshwar, P.6
-
8
-
-
84890434993
-
Connexin43 confers Temozolomide resistance in human glioma cells by modulating the mitochondrial apoptosis pathway
-
Gielen PR, Aftab Q, Ma N, Chen VC, Hong X, Lozinsky S, et al. Connexin43 confers Temozolomide resistance in human glioma cells by modulating the mitochondrial apoptosis pathway. Neuropharmacology 2013;75: 539-48.
-
(2013)
Neuropharmacology
, vol.75
, pp. 539-548
-
-
Gielen, P.R.1
Aftab, Q.2
Ma, N.3
Chen, V.C.4
Hong, X.5
Lozinsky, S.6
-
9
-
-
28644434657
-
Zonula occludens-1 alters connexin43 gap junction size and organization by influencing channel accretion
-
Hunter AW, Barker RJ, Zhu C, Gourdie RG. Zonula occludens-1 alters connexin43 gap junction size and organization by influencing channel accretion. Mol Biol Cell 2005;16:5686-98.
-
(2005)
Mol Biol Cell
, vol.16
, pp. 5686-5698
-
-
Hunter, A.W.1
Barker, R.J.2
Zhu, C.3
Gourdie, R.G.4
-
10
-
-
84925956562
-
The effect of a connexin43-based Peptide on the healing of chronic venous leg ulcers: A multicenter, randomized trial
-
Ghatnekar GS, Grek CL, Armstrong DG, Desai SC, Gourdie RG. The effect of a connexin43-based Peptide on the healing of chronic venous leg ulcers: a multicenter, randomized trial. J Invest Dermatol 2015; 135:289-98.
-
(2015)
J Invest Dermatol
, vol.135
, pp. 289-298
-
-
Ghatnekar, G.S.1
Grek, C.L.2
Armstrong, D.G.3
Desai, S.C.4
Gourdie, R.G.5
-
11
-
-
65449153532
-
Transcription and signalling pathways involved in BCR-ABL-mediated misregulation of 24p3 and 24p3R
-
Sheng Z, Wang SZ, Green MR. Transcription and signalling pathways involved in BCR-ABL-mediated misregulation of 24p3 and 24p3R. EMBO J 2009;28:866-76.
-
(2009)
EMBO J
, vol.28
, pp. 866-876
-
-
Sheng, Z.1
Wang, S.Z.2
Green, M.R.3
-
12
-
-
84943776069
-
A rapid and high content assay that quantitatively mesures autophagy and autophagy flux with potential clincal applications
-
Guo S, Liang Y, Murphy SF, Huang A, Shen H, Sobrado P, et al. A rapid and high content assay that quantitatively mesures autophagy and autophagy flux with potential clincal applications. Autophagy 2015; 11:560-72.
-
(2015)
Autophagy
, vol.11
, pp. 560-572
-
-
Guo, S.1
Liang, Y.2
Murphy, S.F.3
Huang, A.4
Shen, H.5
Sobrado, P.6
-
13
-
-
77953230937
-
A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications
-
Sheng Z, Li L, Zhu LJ, Smith TW, Demers A, Ross AH, et al. A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications. Nat Med 2010;16:671-7.
-
(2010)
Nat Med
, vol.16
, pp. 671-677
-
-
Sheng, Z.1
Li, L.2
Zhu, L.J.3
Smith, T.W.4
Demers, A.5
Ross, A.H.6
-
14
-
-
78549288561
-
MGMT-independent temozolomide resistance in pediatric glioblastoma cells associated with a PI3-kinase-mediated HOX/stem cell gene signature
-
Gaspar N, Marshall L, Perryman L, Bax DA, Little SE, Viana-Pereira M, et al. MGMT-independent temozolomide resistance in pediatric glioblastoma cells associated with a PI3-kinase-mediated HOX/stem cell gene signature. Cancer Res 2010;70:9243-52.
-
(2010)
Cancer Res
, vol.70
, pp. 9243-9252
-
-
Gaspar, N.1
Marshall, L.2
Perryman, L.3
Bax, D.A.4
Little, S.E.5
Viana-Pereira, M.6
-
15
-
-
67649419005
-
Effect of IFN-beta on human glioma cell lines with temozolomide resistance
-
Yoshino A, Ogino A, Yachi K, Ohta T, Fukushima T, Watanabe T, et al. Effect of IFN-beta on human glioma cell lines with temozolomide resistance. Int J Oncol 2009;35:139-48.
-
(2009)
Int J Oncol
, vol.35
, pp. 139-148
-
-
Yoshino, A.1
Ogino, A.2
Yachi, K.3
Ohta, T.4
Fukushima, T.5
Watanabe, T.6
-
16
-
-
84893435197
-
Enhanced MGMTexpression contributes to temozolomide resistance in glioma stemlike cells
-
Qiu ZK, Shen D, Chen YS, Yang QY, Guo CC, Feng BH, et al. Enhanced MGMTexpression contributes to temozolomide resistance in glioma stemlike cells. Chinese J Cancer 2014;33:115-22.
-
(2014)
Chinese J Cancer
, vol.33
, pp. 115-122
-
-
Qiu, Z.K.1
Shen, D.2
Chen, Y.S.3
Yang, Q.Y.4
Guo, C.C.5
Feng, B.H.6
-
17
-
-
84905843043
-
Enhanced anti-tumor effect of zoledronic acid combined with temozolomide against human malignant glioma cell expressing O6-methylguanine DNA methyltransferase
-
Fukai J, Koizumi F, Nakao N. Enhanced anti-tumor effect of zoledronic acid combined with temozolomide against human malignant glioma cell expressing O6-methylguanine DNA methyltransferase. PLoS ONE 2014;9:e104538.
-
(2014)
PLoS ONE
, vol.9
-
-
Fukai, J.1
Koizumi, F.2
Nakao, N.3
-
18
-
-
0035122849
-
Both extraneuronal monoamine transporter and O(6)-methylguanine-DNA methyltransferase expression influence the antitumor efficacy of 2-chloroethyl- 3-sarcosinamide- 1-nitrosourea in human tumor xenografts
-
Chen ZP, Wang ZM, Carter CA, Alley MC, Mohr G, Panasci LC. Both extraneuronal monoamine transporter and O(6)-methylguanine-DNA methyltransferase expression influence the antitumor efficacy of 2-chloroethyl- 3-sarcosinamide- 1-nitrosourea in human tumor xenografts. J Pharmacol Exp Ther 2001;296:712-5.
-
(2001)
J Pharmacol Exp Ther
, vol.296
, pp. 712-715
-
-
Chen, Z.P.1
Wang, Z.M.2
Carter, C.A.3
Alley, M.C.4
Mohr, G.5
Panasci, L.C.6
-
19
-
-
84892441562
-
The evolving landscape of glioblastoma stem cells
-
Yan K, Yang K, Rich JN. The evolving landscape of glioblastoma stem cells. Curr Opin Neurol 2013;26:701-7.
-
(2013)
Curr Opin Neurol
, vol.26
, pp. 701-707
-
-
Yan, K.1
Yang, K.2
Rich, J.N.3
-
20
-
-
80053647284
-
Chemoresistance of glioblastoma cancer stem cells-much more complex than expected
-
Beier D, Schulz JB, Beier CP. Chemoresistance of glioblastoma cancer stem cells-much more complex than expected. Mol Cancer 2011;10:128.
-
(2011)
Mol Cancer
, vol.10
, pp. 128
-
-
Beier, D.1
Schulz, J.B.2
Beier, C.P.3
-
21
-
-
84927153807
-
Real-time visualization of nanoparticles interacting with glioblastoma stem cells
-
Pohlmann ES, Patel K, Guo S, Dukes MJ, Sheng Z, Kelly DF. Real-time visualization of nanoparticles interacting with glioblastoma stem cells. Nano Lett 2015;15:2329-35.
-
(2015)
Nano Lett
, vol.15
, pp. 2329-2335
-
-
Pohlmann, E.S.1
Patel, K.2
Guo, S.3
Dukes, M.J.4
Sheng, Z.5
Kelly, D.F.6
-
22
-
-
77956294442
-
Gamma-secretase inhibitors enhance temozolomide treatment of human gliomas by inhibiting neurosphere repopulation and xenograft recurrence
-
Gilbert CA, Daou MC, Moser RP, Ross AH. Gamma-secretase inhibitors enhance temozolomide treatment of human gliomas by inhibiting neurosphere repopulation and xenograft recurrence. Cancer Res 2010;70: 6870-9.
-
(2010)
Cancer Res
, vol.70
, pp. 6870-6879
-
-
Gilbert, C.A.1
Daou, M.C.2
Moser, R.P.3
Ross, A.H.4
-
23
-
-
84897438541
-
Purinergic control of AMPK activation by ATP released through connexin 43 hemichannels - Pivotal roles in hemichannel-mediated cell injury
-
Chi Y, Gao K, Li K, Nakajima S, Kira S, Takeda M, et al. Purinergic control of AMPK activation by ATP released through connexin 43 hemichannels - pivotal roles in hemichannel-mediated cell injury. J Cell Sci 2014; 127:1487-99.
-
(2014)
J Cell Sci
, vol.127
, pp. 1487-1499
-
-
Chi, Y.1
Gao, K.2
Li, K.3
Nakajima, S.4
Kira, S.5
Takeda, M.6
-
24
-
-
79955501784
-
Connexin 43 connexon to gap junction transition is regulated by zonula occludens-1
-
Rhett JM, Jourdan J, Gourdie RG. Connexin 43 connexon to gap junction transition is regulated by zonula occludens-1. Mol Biol Cell 2011;22: 1516-28.
-
(2011)
Mol Biol Cell
, vol.22
, pp. 1516-1528
-
-
Rhett, J.M.1
Jourdan, J.2
Gourdie, R.G.3
-
25
-
-
84859802065
-
Gap26, a connexin mimetic peptide, inhibits currents carried by connexin43 hemichannels and gap junction channels
-
Desplantez T, Verma V, Leybaert L, Evans WH, Weingart R. Gap26, a connexin mimetic peptide, inhibits currents carried by connexin43 hemichannels and gap junction channels. Pharmacol Res 2012;65:546-52.
-
(2012)
Pharmacol Res
, vol.65
, pp. 546-552
-
-
Desplantez, T.1
Verma, V.2
Leybaert, L.3
Evans, W.H.4
Weingart, R.5
-
26
-
-
78649739295
-
Connexin 43 mimetic peptide Gap27 reveals potential differences in the role of Cx43 in wound repair between diabetic and non-diabetic cells
-
Pollok S, Pfeiffer AC, Lobmann R, Wright CS, Moll I, Martin PE, et al. Connexin 43 mimetic peptide Gap27 reveals potential differences in the role of Cx43 in wound repair between diabetic and non-diabetic cells. JCell Mol Med 2011;15:861-73.
-
(2011)
JCell Mol Med
, vol.15
, pp. 861-873
-
-
Pollok, S.1
Pfeiffer, A.C.2
Lobmann, R.3
Wright, C.S.4
Moll, I.5
Martin, P.E.6
-
27
-
-
80051759671
-
ATP and glutamate released via astroglial connexin 43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannels
-
Orellana JA, Froger N, Ezan P, Jiang JX, Bennett MV, Naus CC, et al. ATP and glutamate released via astroglial connexin 43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannels. J Neurochem 2011;118:826-40.
-
(2011)
J Neurochem
, vol.118
, pp. 826-840
-
-
Orellana, J.A.1
Froger, N.2
Ezan, P.3
Jiang, J.X.4
Bennett, M.V.5
Naus, C.C.6
-
28
-
-
35148854098
-
Autocrine glutamate signaling promotes glioma cell invasion
-
Lyons SA, Chung WJ, Weaver AK, Ogunrinu T, Sontheimer H. Autocrine glutamate signaling promotes glioma cell invasion. Cancer Res 2007; 67:9463-71.
-
(2007)
Cancer Res
, vol.67
, pp. 9463-9471
-
-
Lyons, S.A.1
Chung, W.J.2
Weaver, A.K.3
Ogunrinu, T.4
Sontheimer, H.5
-
29
-
-
33646882667
-
Temozolomide in resistant or relapsed pediatric solid tumors
-
De Sio L, Milano GM, Castellano A, Jenkner A, Fidani P, Dominici C, et al. Temozolomide in resistant or relapsed pediatric solid tumors. Pediatric Blood Cancer 2006;47:30-6.
-
(2006)
Pediatric Blood Cancer
, vol.47
, pp. 30-36
-
-
De Sio, L.1
Milano, G.M.2
Castellano, A.3
Jenkner, A.4
Fidani, P.5
Dominici, C.6
-
30
-
-
84869506069
-
Temozolomide and unusual indications: Review of literature
-
Tatar Z, Thivat E, Planchat E, Gimbergues P, Gadea E, Abrial C, et al. Temozolomide and unusual indications: review of literature. Cancer Treat Rev 2013;39:125-35.
-
(2013)
Cancer Treat Rev
, vol.39
, pp. 125-135
-
-
Tatar, Z.1
Thivat, E.2
Planchat, E.3
Gimbergues, P.4
Gadea, E.5
Abrial, C.6
-
31
-
-
84919773190
-
A multicenter phase i dose escalation trial to evaluate safety and tolerability of intra-arterial temozolomide for patients with advanced extremity melanoma using normothermic isolated limb infusion
-
Beasley GM, Speicher P, Augustine CK, Dolber PC, Peterson BL, Sharma K, et al. A multicenter phase I dose escalation trial to evaluate safety and tolerability of intra-arterial temozolomide for patients with advanced extremity melanoma using normothermic isolated limb infusion. Ann Surg Oncol 2015;22:287-94.
-
(2015)
Ann Surg Oncol
, vol.22
, pp. 287-294
-
-
Beasley, G.M.1
Speicher, P.2
Augustine, C.K.3
Dolber, P.C.4
Peterson, B.L.5
Sharma, K.6
-
32
-
-
84908405540
-
Trial of a 5-day dosing regimen of temozolomide in patients with relapsed small cell lung cancers with assessment of methylguanine-DNA methyltransferase
-
Zauderer MG, Drilon A, Kadota K, Huberman K, Sima CS, Bergagnini I, et al. Trial of a 5-day dosing regimen of temozolomide in patients with relapsed small cell lung cancers with assessment of methylguanine-DNA methyltransferase. Lung Cancer 2014;86:237-40.
-
(2014)
Lung Cancer
, vol.86
, pp. 237-240
-
-
Zauderer, M.G.1
Drilon, A.2
Kadota, K.3
Huberman, K.4
Sima, C.S.5
Bergagnini, I.6
|